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SUMMARY 
• The evidence for the integration of the submandibii- 
lar gland (SMG) into the neuroimmiinoregulatory network is 
reviewed. In laboratory rodents, factors extracted from the 
SMG were shown to stimulate lymphocyte proliferation, to 
affect the weight of the thymus, spleen and lymph nodes and to 
induce immunosuppression in several in vivo and in vitro mo 
dels. The SMG produces significant amount of nerve growth 
factor (NGF), epidermal growth factor (EGF), transforming 
growth factor-/3, and kallikreins. These factors are secreted 
into the saliva and affect immune and mitcosal tissues and 
nerve endings in the gastrointestinal tract. They may thus play 
a role in the regulation of mucosal immune/inflammatory re 
sponses. The major salivary glands also produce antimicro 
bial proteins and secretory IgA antibodies which are essen 
tial factors in mucosal host defence. SMG-derivedNGF, EGF 
and glandular kallikrein are delivered into the bloodstream 
where they may act as important systemic immunoregulators 
and exert regulatory influences on the neuroendocrine system. 
Growth hormone, prolactin, androgens, thyroid hormone and 
corticosteroids regulate protein synthesis in the SMG, where 
as secretory activity is regulated by sympathetic, parasympa- 
thetic and peptidergic nerve fibres. Steroid hormones and 
cytokines as interleukin-la, -1(3 , tumor necrosis factor-a , 
interferon-y have major regulatory influence on protein 
secretion, including the secretion ofimmunoglobulin into the 
saliva. The SMG interacts with the mucosal and svstemic 
compartments of the immune system, with the central and 
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peripheral nervous systems, with the pituitary gland, and with 
peripheral endocrine organs. These interactions enable the 
SMG to exert regulatoiy influences on immune/inflammatory 
reactions in the gastrointestinal tract, in the lungs, and 
possiblv elsewhere. It is suggested that these functions make 
this gland a key regulatory organ in the 
neuroimmiinoregulatory network. (Biomed Rev 1998; 9: 79-
91) 
INTRODUCTION 
• Ever since the classical studies of Pavlov, it is of com 
mon knowledge that the function of the major salivary glands 
is intimately regulated by the central nervous system. It is now 
certain that the salivary glands also perform an important immu- 
noregulatory function, and that immune reactions can be condi 
tioned in the Pavlovian sense (1,2). Early studies showed that 
the submandibular gland (SMG) produces, stores, andreleases 
biologically active molecules, such as kallikrein (3), nerve growth 
factor (NGF) (4), and epidermal growth factor (EGF) (5), which 
are now known to regulate immune reactions. It has also been 
demonstrated that the function of the SMG is regulated by 
hormones. In the 1960s, SMG extracts were found to reduce the 
weight of the thymus and lymphoid organs (6) and to produce 
immunosuppression (7). The role of the major salivary glands in 
immunoregulation and in the neuroimmunoregulatory network 
is poorly defined. Here we review the possible role of the SMG 
in the neuroimmunoregulatory network,providing the availa 
ble evidence in order to clarify some key questions and identify 
others that need to be answered. 
THE SALIVARY GLANDS 
• Majorsalivary glands,including theSMG,parotidand 
sublingual glands, and minor glands associated with the oral 
  
  
mucosa, may be distinguished in mammals. The glandular 
epithelial cells may be divided into two functionally distinct 
groups, acinar and ductal. The secretory end piece consists of 
acinar cells of one or two types. These cells generate all the 
saliva fluid and approximately 85% ofthe excreted proteins from 
the gland. The fluid is derived from the vascular bed and is 
isotonic at this stage. In the SMG, the acini are connected to 
each other by intercalated ducts which lead to the granulated 
convoluted tubules which in turn join into the striated excretory 
duct. Ductal cells reabsorb from the primary saliva most ofthe 
Na~ and Cl~ while secreting small amounts of K" and HCO°. 
Ductal cells also secrete proteins into the saliva which is 
markedly hypotonic by the time it enters the mouth. Salivary 
gland secretion is under neural control. The glands receive 
sympathetic, parasympathetic andpeptidergic innervation. 
Sympathetic stimulation leads to high levels of protein secretion 
and parasympathetic stimulation induces fluid output. Acinar 
cells have a-, (3-adrenergic, and muscarinic cholinergic receptors 
and receptors for vasoactive intestinal peptide (VIP), substance 
P (SP), prostaglandins and many peptide hormones, including 
vasopressin and parathyroid hormone. Cyclic AMP, G-proteins 
and Ca2~ all participate in signal transduction for the regulation of 
salivary secretion. The secreted fluid, electrolytes and proteins are 
the result of a tightly regulated process, and little if any 
material enters the saliva accidentally or by leakage from the 
serum (8,9). 
The macromolecules present in saliva fall into various families: 
histatins (2-4 kD), statherins (4-5 kD), lysozyme (14 kD), cystatins 
(14 kD), proline-rich proteins (10-30 kD), carbonic anhydrases 
(42-45 kD), amylases (55-60 kD), peroxidases (75-78 kD), lacto-
femn(75-78kD),mucinNo2(130kD), secretory IgA (380 kD), 
andmucinNo 1 (>1000kD). These proteins are multifunctional 
and participate in buffering (carbonic anhydrases, histatins), 
digestion (amylases, mucins), mineralization (histatins, proline-
rich proteins, statherins), lubrication and viscosal elasticity 
(mucins, statherins), tissue coating (amylases, cystatins, proline-
rich proteins) and many possess antimicrobial properties (10). 
IMMUNOREGULATORY FACTORS OF THE 
SUBMANDIBULAR GLAND 
• The SMG produces numerous biologically active 
polypeptides which may be classified into three major groups: 
(/) growth factors, such as EOF and NGF, (//) homeostatic pep- 
tidases, such as kallikrein and renin, and (Hi) regulatory poly 
peptides, such as transforming growth factor-[3 (TGF-p), gluca- 
gon and cytokines. Polypeptides of the first two groups are 
stored in secretion granules ofthe convoluted tubular cells and 
are frequently released separately. Peptides ofthe third group 
have a less defined localization and the secretion patterns are 
not well studied (11). Here we restrict our discussion to those 
factors that have a well-defined immunological effect (Table 1). 
• Transforming growth facto r-p 
TGF-J3 is a dimeric peptide presenting several isoforms(12).The 
growth promo ting effect of TGF-P is likely to be indirect through 
the stimulation of new extracelluar matrix, changes of adhesion 
molecules and the alteration of growth factor secretion by 
various cells (13). Thus TGF-P should be considered a regulatory 
cytokine that exerts a complex effect on inflammatory and 
immune responses. It acts as a chemoattractant for monocytes 
(14), neutrophils (15-17) and lymphocytes (18), and activates 
monocytes to secrete cytokines and growth factors (14,19). 
Later, activated monocytes downregulate the number of their 
TGF-P receptors and become refractory or even suppressed by 
this cytokine (20). TGF- p stimulates inflammati on at the beginning 
while later supports its resolution and contributes to healing. 
Resting T cells are not affected significantly by TGF-P, while 
activated CD4~ T cells are suppressed (21,22) and CDS" T cells 
are stimulated (23,24). B cell proliferation and the production of 
IgG and IgM are suppressed (25,26). TGF-P also supports the 
switch of antibody response to IgA production (27-29). 
• Epidermal growth factor and related molecules 
EGF and TGF-P , both of which are present in the SMG, have a 
similar biological effect and bind to the same type of receptor, a 
170 kD molecul which is usually referred to as the EGF receptor 
(30-32). EGF and TGF-P function as growth factors for epithelial 
cells and fibroblasts (33) and are considered important for the 
maintenance of mucosal integrity (34-39). EGF stimulates T cell 
proliferation, increases the production of interferon-y (IFN-y) 
and reduces T suppressor cell activity (40-42). EGF stimulates 
macrophages for chemotaxis and phagocytosis (43,44). These 
activities suggest that EGF is immunostimulatory and proin-
flammatory. Nevertheless, EGF was shown to suppress delayed-
type hypersensitivity (DTH) reactions (45). 
• Nerve growth factor 
NGF was first described in the mouse SMG (46). It stimulates the 
growth of sympathetic ganglia which innervate immune organs 
(47). NGF was shown to increase the number and size of mast 
cells in tissues of neonatal mice (48), and stimulate histamine 
release from mast cells, both in vivo (49) and in vitro (50,51). NGF 
also stimulates the development of hemopoietic colonies (52, 
53) and increases phagocytosis and chemotaxis of neutrophils 
(52,54). These effects of NGF should suggest a proinflammatory 
role, yet NGF was shown to suppress in vivo inflammatory 
reactions in several models (55,56). The reason for this paradox is 
at present not known. NGF receptors are present on both B 
lymphocytes and antigen presenting cells (57-59). Likewise, 
lymphocyte growth is stimulated by NGF in vitro (60-62). 
Production of IgM (62) and IgG4 (63) by human B cells is 
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Kallikreins are proteolytic enzymes which belong to the family of 
serine proteases. There are 20 kallikreingenes in rodents (64). Of 
these, at least 6-7 genes are expressed in the rat SMG (65). 
Plasma kallikrein differs in molecular weight and enzymatic 
activity from tissue or glandular kallikreins. Members of the 
latter group are differentially expressed in different tissues (64). In 
this review we designate the product of the hRK ALL gene in 
humans, the mGK-6 gene in the mouse, and the rGK-1 gene in 
the rat as glandular kallikrein (GK) (66). In addition, the general 
term kallikrein will be used for any unspecified member of the 
kallikrein family. The best studied substrate for GK is kininogen 
produced by the liver (66), which has two forms: low molecular 
weight kininogen (50 kD) and high molecular weight kininogen 
(120 kD). Plasma kallikrein produces the nonapeptide bradyki-
nin from kininogen. On the other hand, GK gives rise in most 
other species to a decapeptide, kallidin (Lys-bradykinin), which 
is biologically active but may also be further processed into 
bradykinin. In the the rat, GK has been reported to produce 
bradykinin (67). GK may activate or regulate other immunologi-
cally active factors of the SMG, including NGF, EGF/TGF-oc and 
TGF-|3. In extrasalivary tissues, GK may also process other 
important molecules, such as prolactin (68,69). 
Kallikrein has a mitogenic effect on both thymocytes and T and B 
lymphocytes (70) and was shown to be involved in Ig isoty-pe 
control. Ishizaka (71) described a kallikrein-like factor, gly-
cosylation-enhancing factor, which induced CD4~ T cells to 
produce IgE potentiating factor and favoured IgE production. 
Serine proteases from Schistosoma mansoni schistosomula 
enhanced IgE production (72). In vitro, the addition of kallikrein 
and other serine proteases to B cells stimulated with lipopolysac-
charide and IL-4 enhanced the production of IgE, IgG 1 or IgG3 
(73). Experiments in our laboratories demonstrated that a 40 kD 








lymphocyte proliferation and the suppression of in vivo immune 
reactions (74). The purified 40 kD protein catalyzed the hydrolysis 
of a-N-benzoyl-arginine ethyl ester. This esterase activity was 
inhibited by the protease inhibitor aprotinin. The sequence of the 
first 25 amino acids demonstrated that this protein was rat 
glandular kallikrein (rGK). When added to cultures of murine 
lymph node cells suboptimally stimulated with the T cell mito-
gen concanavalin A, rGK markedly stimulated the proliferative 
activity of these cells (Fig. 1). When injected into mice, rGK 
suppressed the DTH response to picryl chloride (Fig. 2), and the 
plaque-forming cell reaction in the spleens of animals immunized 
with sheep red blood cells (75). Similar effects were induced with 
glandular kallikrein fromporcine pancreas (pGK). Moreover, the in 
vitro and in vivo effects were abolished by aprotinin either 
added to the tissue culture medium or injected into the animals 
immediately before rGK or pGK. This gave further support to the 
conclusion that the immunological effects we observed were 
due to activity of rGK and indicated that rGK may act via the 
mediation of some product(s) of its enzymatic activity on an as 
yet unidentified substrate. 
THEIMMUNEFUNCTIONOFSALIVARYANDLACRIMALGLANDS 
• The salivary and lacrimal glands secrete antimicrobial 
proteins, antibodies and cytokines, which play an important role 
in host defence by natural immune mechanisms. Specific im 
mune defence is also mediated by these glands primarily by the 
secretion of IgA antibodies. In the saliva, amylase, cystatins, 
histatins, mucins andperoxidases, have antibacterial, antiviral 
(cystatins and mucins) and antifungal (histatins) effects (10). C- 
reactive protein (CRP) is also present in saliva (76) and has the 
capacity to combine with surface moieties of diverse microor 
ganisms followed by immune activation and the stimulation of 
an inflammatory response (77). There is a correlation between 
salivary and serum CRP levels in man (76). In the salivary gland, 
IgA is produced by plasma cells and secreted by ductal acinar 
cells that express surface receptors (secretory component, SC) 
for polymeric IgA molecules. IgA combines with SC on the 
epithelial cell surface, and is internalized and released onto the 
mucosal surface. The salivary glands are part of the "common 
mucosal immune system " which provides defence of mucosal 
surfaces. After antigenic stimulation at a certain mucosal site, 
IgA forming cells enter the blood stream via the thoracic duct 
and redistribute to other sites. Thus, the external secretions of 
glands will contain IgA antibodies specific for the antigen at 
sites that are anatomically remote from the primary site of 
stimulation. This is valid for B cells producing immunoglobulins 
other than IgA. For this reason, the analysis of salivary antibod 
ies can be used to provide a general picture of mucosal immunity 
(78-82). 
Some epithelial cells express majorhistocompatibility complex 









II is expressed only by the glandular epithelium of SMG and by 
dendritic cells in all glands (83). Giaft-versus-host reaction 
increased the expression of MHC in the rat SMG (84). The 
glandular expression of MHC II in humans was associated with 
Sjogren's syndrome (SS), symptomatic xerostomia, rheumatoid 
arthritis, and systemic lupus erythematosus. Expression was 
confined to epithelial cells in close proximity to lymphocytic 
infiltrates (85,86). Helper T lymphocytes for cell mediated (Thl) 
and humoral (Th2) immunity are both present in the SMG (87). In 
addition to T lymphocytes, mucosal epithelial cells are also 
producing immunoregulatory cytokines, such as IL-6 andTGF-P. 
Production was significantly upregulated as a consequence of 
local infection (80). Cytokines also regulate glandular epithelial 
cells, e.g. IFN-yinhibits epithelial cell growth that is syner-
gistically enhanced by TNF-a (8). The secretory component 
plays a critical rate-limiting role in the secretion of polymeric IgA 
onto mucosal surfaces. This process is regulated by hormones, 
such as androgens, estrogens, progestins, glucocorticoids, 
prolactin, and thyroid hormone, neurotransmitters and neu-
ropeptides (adrenergic and cholinergic transmitters, VIP) and 
by cytokines (IL-1 a, -1 (3, TNF-a, IFN-y) in a tissue- and organ-
specific manner. Thus in the lacrimal gland, androgen, VIP, the 
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Figure 1. Increased proliferative activity ofConA-
stimula-ted A/J lymph node cells induced bv rGK and 
pGK and reversal of this effect with aprotinin. 
TherGKandpGKdoses were 1.78 fig/culture (final 
concentration 0.22 jJ.M/1). Aprotinin (Apr) doses were 
6 jjg, 3 fig, or 1.5 fig per culture (4.6 u.M/1, 2.3 /JM/I, 
and 1.15fjM/l, respectively). Results are expressed as 
counts per minute (CPM) in triplicate cultures (± SD). 
 













capable of inducing a rise in SC, whereas cholinergic agents are 
inhibitory. Androgens also promote the production of SC in the 
SMG, whereas the cholinergic agonist carbachol is inhibitory 
(89-91). The synthesis of GK and protein synthesis in general is 
dependent on the joint action of androgen, thyroxin, prolactin and 
growth hormone in the rat SMG (92). 
IMMUMOREGULATIOM BY THE 
SUBMANDIBULAR GLAND 
• Early investigations with SMG extracts and surgical 
removal of the gland indicated that factors capable of inducing 
the atrophy of the thymus and lymphoid organs, as well as 
stimulatory factors, are produced (reviewed in 11). Extracts from 
male SMG induced a significant retardation of skin allograft 
rejection (7) and suppression of both the antibody and the DTH 
responses (45,93). Increased immune activity was observed in 
syalectomized animals and the immunosuppressive effect of 
extracts was confirmed (93-97). In our laboratory it was revealed 
that one of the immunosuppressive factors produced by the 
SMG of male rats is identical with TGF-(3 (98). Another factor 
stimulated the mitogenic response of lymphocytes in vitro, but 
exerted a profound immunosuppressive effect /;; vivo. This has 
been identified as GK after sequencing the end terminal portion 
of the 40 kD protein (75). Hypophysectomy of rats led to a pro 
found atrophy of the SMG and to the complete disappearance 
of GK (92). Physiological replacement doses of prolactin, lu- 
teinizing hormone, or thyroid-stimulating hormone partially 
restored the production of GK. Combination treatment with all 
three of these hormones led to a more complete restoration. 
Subsequent experiments showed that combined treatment with 
thyroid hormone, testosterone and prolactin results in maximal 
restoration. Thus the SMG has been identified as a new prolac 
tin target. Other investigators observed that the immunomo- 
dulatory function of the SMG is regulated by the superior cer 
vical ganglion (8,99,100). The possibility was also raised that 
not all functions of the SMG are under sympathetic control 
(101,102). 
ENDOCRINE REGULATION OF SUBMANDIBULAR 
GLAND FUNCTION 
• The SMG is more developed in males than in females 
and it regresses in castrated males (103 -105). Androgens,thyroid 
and adrenocortical hormones are necessary for the normal 
development of the gland and for the production of biologically 
active polypeptides (106-108). In rats, NGF, EGF, kallikrem, 
insulin (10,109,110), renin (111), and the production of various 
enzymes have been shown to be dependent on sex hormones 
and thyroxin. EGF, NGF and kallikreins are produced by the 
glandular cells of the convoluted tubules (112). Insulin and GK 
seem to be preferentially produced in the intercalated tubules 
(113) and other factors may be produced by acinar cells (114). 
Specific induction of certain factors by certain hormones and 
different responses among various animal strains of the same 
species are possible (115). The SMG affects testicular function 
either by acting on the hypophysis or via EGF (116-121). It also 
affects the uterus by the modulation of ovarian hormones (122). 
NEURAL REGULATION OF SUBMANDIBULAR 
GLAND SECRETIONS 
• The SMG receives both sympathetic and parasympa- 
thetic mnervation. The parasympathetic system stimulates the 
glandular acinus leading to the secretion of large volumes of 
saliva with low concentrations of biologically active polypep 
tides (123-125). P-adrenergic stimulation increases the synthe 
sis and release of these polypeptides (114,126,127). The secre 
tion of both growth factors and homeostatic proteases by the 
convoluted tubules is stimulated by a-adrenergic agents (128), 
which leads to the appearance of large amounts of kallikrein 
(129),NGF(130),EGF(131),andrenin(l 32) in the saliva, whereas 
p-adrenergic agents exert a significantly lesser effect. However, 
a-adrenergic agents do not increase NGF release into the 
bloodstream. In rats, the electrical stimulation of the sym 
pathetic trunk leads to a large increase of kallikrein in the saliva 
and bloodstream, while parasympathetic stimulation is ineffec 
tive (133,134). The effect of sympathetic stimulation may be 
blocked by ocl -adrenergic.antagonists (13 5). a-adrenergic ago 
nists significantly increase salivary excretion, but not the endo 
crine release of kallikrein, while P-adrenergic agonists induce a 
lesser effect, and cholinergic agents are ineffective. These re 
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Figure 2. Effects of rGK and pGK on the DTH response of 
A/ J mice immunized withpicrvl chloride and reversal of 
such effects with aprotinin. Aprotinin (Apr) was 
injected sub-cutaneously as a full dose (190 /.tgper 
animal) or as a half dose (95 Hgper animal). Fifteen 
minutes later the animals received a further 
subcutaneous injection of rGK or pGK in 0.2 ml of PBS 
or PBS only. Results are expressed in terms of the 
increase of the thickness of the challenged ear over the 
precliallenge values. Unimmunized controls (not 





kallikrein requires both cc-adrenergic stimulation and another as 
yet unidentified neurotransmitter (136). A smaller but 
significant constitutive release of kallikrein into the blood has 
been demonstrated (135),as well as a similar dual endocrine 
regulation ofNGF and EGF (137) and of renin (138) release was 
also observed in mice. 
THE SALIVARY GLANDS AMD DISEASE 
• The analysis of saliva is informative with regard to 
general health and also reflects environmental influences. 
Through salivary analysis one may obtain information regard 
ing (z) tissue levels of drugs, (ii) emotional status, (Hi) hormonal 
status, (iv) immunological status and immune responsiveness, 
(v) neurological status, and (vi) nutritional and metabolic con 
ditions. Accordingly, salivary analysis is useful in a number of 
medical problems (13 9,140,140a). The salivary glands are often 
affected by inflammatory disease (141). In man, the most fre 
quent inflammatory disease of the salivary and lacrimal glands 
is Sjogren's syndrome (SS). This is characterized by lympho- 
cytic infiltration of the gland and the presence of plasma cells 
producing IgA autoantibodies. The disease shows a female 
prevalence and may lead to the failure of salivary and lacrimal 
glands causing xerostomia and keratoconjunctivitis sicca, re 
spectively. Although SS may occur as an isolated disease, it is 
frequently associated with systemic immune disorders, such as 
systemic lupus erythematosus, rheumatoid arthritis, sclero- 
derma, and sarcoidosis. Immune complexes, autoantigens and, 
more recently, retro viruses (HTLV-1, HIV) have been proposed 
as causative agents of SS (142-147). Transgenic mice carrying 
the tax gene of HTLV-1 develop exocrinopathy which resembles 
SS (148). Lacrimal and salivary gland inflammation occurs in 
spontaneous autoimmune mice carrying the lymphoproliferati ve 
(Ipr) gene. Salivary gland inflammation correlates positively 
with serum immune complexes in such mice. A number of other 
autoimmune mouse strains develop SS-like disease: MRL/n, 
NZB, NZB/NZW, BDF1, non-obese diabetic (NOD), and 
PalmerstonNorth(149). In mice, experimental graft-verau'-host 
disease leads to sialoadenitis in their SMG, characterized by 
mononuclear infiltration with T cell predominance (150). The 
salivary glands of autoimmune MRL/lpr mice are infiltrated 
predominantly by T cells which show oligoclonality (151). In 
these animals, CD4~ T cells play an important role in the 
pathogenesis of SS-like disease, as is the case in patients with 
SS (152). Autoimmune sialoadenitis may be induced in Lewis 
rats by immunization with salivary tissues in which CD4~T cells 
play a pathogenic role (153). Salivary gland inflammation and 
lymphocytic infiltration in female MRL/Mpj-lpr/lpr mice was 
significantly reduced by treatment with 19-nortestosterone, 
testosterone, cyclophosphamide or dexamethasone. The infil 
tration of the lacrimal glands was reduced by 19-nortestosterone 
or cyclophosphamide (154). Other immune/inflammatory dis 
eases of the salivary gland in man are benign lymphoepithelial 
lesions (Mikulicz's syndrome) (155), allergic submandibular 
salivary disease (156), lymphadenopathy in the submandibular, 
submental and upper cervical region (Kimura's disease) (157), 
and salivary Wegener's disease caused by autoantibodies to 
neutrophil leukocytes (158). 
EGF shows a diurnal rhythm in human saliva but not in serum. 
Salivary EGF levels are increased in patients with inflammatory 
disease or with head and neck tumors (159,160). The induction of 
novel cells forming small glands around gastrointestinal 
ulcers which secrete EGF has been described in man (161). In 
the saliva of patients with gingivitis and periodontitis, cystatin S 
and C were found to be elevated (162). 
NOD mice show lymphocytic infiltration and glandular 
disorganisation of the SMG coupled with a profound reduction of 
EGF in the gland (163). Streptozotocin-mduced diabetic mice show 
low serum EGF levels and develop oligozoospemiia. EGF 
treatment increased sperm count and treatment with insulin 
restored the SMG, plasma EGF concentration and sperm counts to 
normal levels (164). In the salivary gland of NOD mice, (3-
adrenergic receptors are downregulated (165). Amylase levels 
were reduced significantly in the parotid gland and pancreas of 
diabetic rats which could be reversed by insulin (166). i 
CONCLUSION 
• Mucosal membranes are constantly exposed to anti- 
genie material, microbes, irritants, and toxins. Under these con 
ditions, an exaggerated response to harmless food or airborne 
antigens is just as dangerous as an insufficient immune re 
sponse to pathogenic agents. Much of mucosal immune defen 
ce takes place on the surface of mucous membranes, which falls 
outside of the body. Therefore, self-nonself discrimination by 
the immune system is not sufficient for host defence. For this 
reason, neuroimmuneregulatory factors should play a primary 
role in assuring that harmless antigens are tolerated, whereas 
adequate defence is mounted against pathogens. The predomi 
nance of tolerance induction against orally introduced antigens 
is firmly established in immunology (167-169). Animal experi 
ments indicate that the induction of oral tolerance may even be 
useful for the treatment of some systemic immune disorders. It 
appears that differences in antigen presentation by epithelial 
cells and of the cytokines involved play an important role in 
deviating the immune response against orally administered 
antigens towards suppression rather than immunity (167). Oral 
treatment with the specific antigen inhibits autoimmune disease 
in experimental animals. This information coupled with the ob 
servation that systemic autoimmune disease is often associat 
ed with SS, suggests that immune-regulation by the major sa 
livary glands plays an important role in systemic immunoregu- 
lation. The major salivary glands are ideally suited to provide the 
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ry factors exert their immunomodulating and protective effects at 
distant portions of the gastrointestinal tract after passing 
down from the oral cavity. This capability is further amplified by 
the secretion of IgA antibodies against pathogens which had 
previously triggered a primary immune response at any remote 
site within the mucosal system. Experiments in rodents indicate 
that the SMG produces immunoregulatory hormones, cytoki-
nes and enzymes that interact with the nervous, endocrine and 
immune systems, and with mucosal tissue. These regulatory 
factors are delivered into the saliva and/or the blood, in 
response to neural, hormonal or immune/inflammatory signals. 
These attributes make the SMG a key regulatory organ in the 
neuroimmune network which is concerned not only with host 
defence, but also with the prevention of inappropriate reactions, 
e.g. autoimmunity, that otherwise could be triggered by food 
antigens. 
Some important questions with regard to the role of the SMG in 
the neuroimmunoregulatory network remain unanswered. For 
instance, we do not know the details of immunoregulation by 
salivary factors. It is not known of whether local regulation 
mediated by saliva or the systemic immunomodulatory effect 
of SMG is predominant. Itis not dearwhetherimmunoregulation 
by major salivary glands is essential for immune homeostasis or it 
is redundant in nature. The question is further complicated by the 
existence of species- and sex-related differences. The salivary 
regulatory factors may exert a systemic effect by (/) direct 
endocrine release from the glandular tubular cells, (//) through 
reabsorption from the intraglandular ducts, or (///) reabsorption 
from the gastrointestinal tract after swallowing (70). These 
possibilities remain to be investigated. It has been observed that 
the blood in the veins draining the SMG contained more ka-
llikrein than the arterial blood and that both kallikrein and tonin 
levels increased in the venous blood of SMG after sympathetic 
stimulation (134,170). Ductal reabsorption is suggested by the 
finding that l2:T-kallikrein enters the blood after retrograde inj 
ection into the excretory duct (171). Immunochemical studies in 
mice suggested that kallikrein and renin are constitutively 
secreted from the basolateral surface of tubular cells and reach 
the blood via fenestrated endothelium underlying the ducts 
(172). At least some factors secreted in saliva exert direct effects on 
mucosa-associated tissues. The effect of EGF on the buccal and 
gastric mucosa is particularly documented (34,35) and 
supports this possibility. Also, cells of mucosal lymphoid 
tissues (173) and tooth pulp (174) possess NGF receptors. 
Another such factor may be GK which is probably resistant to 
digestion by enteric proteases (66) and thus may be able to exert its 
effect in lower parts of the gastrointestinal tract. The effects 
induced by salivary regulatory factors on intestinal lymphoid 
cells may affect other lymphoid organs via lymphocyte recircu-
lation (175). Most of the biologically active factors producedby the 
SMG may be found in other tissues. The extirpation of SMG either 
failed to produce significant decrease in levels of EGF 
(131), NGF (176) or renin (177,178) in the serum or caused only 
transient reductions followed by recovery to normal values. 
This suggests that the SMG has a contributory role in 
immunoregulation by these factors. However, because of its 
strategic location, the SMG and other salivary glands are 
capable of dramatically increasing the output of these 
regulatory factors into the saliva and possibly also into the 
blood under the influence of the autonomic nervous system 
(135). In fighting mice, for example, NGF level was significantly 
elevated in the blood and affected the adrenal glands, mast cells, 
behavior and inflammatory reactions (see 179, Aloe and Fiore, 
this volume of Biomedical Reviews). The interaction of the 
SMG with the gonads and the regulation of SMG and immune 
functions by sex hormones is intriguing. Factors secreted by the 
SMG appear to affect gonadal and adrenal function. Actually 
the SMG may affect immune responses through this pathway. 
Some SMG factors show marked species related differences. 
Tonin, an enzyme in the kallikrein family, for example, is present 
in large amounts in the rat SMG (65) but has not been 
demonstrated in other species. Renin was found in murine SMG 
but not in the rat (180). NGF is contained in large amounts in 
mouse SMG (46,47), whereas the human gland contains smaller 
amounts. In contrast, the human parotid secretes six-fold more 
EGF than the SMG (159). Some other factors, such as kallikrein and 
EGF, have been found in several species, including man, rat and 
mouse. The immunoregulatory effects of SMG extract have also 
been observed in various species, such as rat, mouse and cattle 
(181). Although it is clear that species related differences 
exist, it appears that the SMG and perhaps some of the other 
salivary glands, perform an important immunoregulatory function 
in all the mammalian species so far examined. The sex 
dimorphism in SMG function and regulation appear to be 
quantitative rather than qualitative. The female gland is smaller in 
many species and consequently contains less biologically active 
factors. Differences in immune responsiveness of males and 
females are also well known. It is possible that some of these 
differences may be explained in the future by the different 
ability of the SMG to secrete regulatory factors. 
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